Member Info for CHELSEA7

Got no issues with the University spending on initial R & D, as long as we benefit too. Which we will.

Looks like the basis for something in the update?

Great link Dragon, I would sure like to know ""why""

We are particularly excited to be part of the Continuum family as it allows us understand why some patients respond very well to treatment and become long term cancer survivors. As part of this project we have already identified novel targets and unique immune receptors which we believe may be important in the long term survival of several cancer patients. We can now use these receptors to target these proteins in other less fortunate cancer patients. We also integrate closely with other Continuum members from other Universities who are focusing on other aspects of cancer biology in long term cancer survivors.
Professor of Cancer immunotherapy, Lindy Durrant at the University of Nottingham

Hi, you were reading my mind, Ihad just double checked that it was the 31st of January last year. Well I had a feeling we just might get the Interims and Update last Monday and just perhaps this coming Monday will be the day, the day before the World Cancer Conference which begins on the 4th Feb.

We know the cash burn, so we are wanting to hear about the three trials, SCIB1, SCIB2 and MOD1, a Fourth Collaboration on the Third Platform will never be far away, and lets face it the previous three have kept the share above 5p, into the 6/8.50 range.

What else? Well that is anybodies guess, for me I would choose to hear the IND has been Approved by the FDA for SCIB1, but we know the first application was never RNSed on submission. Commercial deals?? Well just bring them on, how are things progressing with BioNTech, for an example, but I can"t help feeling the Third Platform will provide us with our first financial commercial deal.

As far as any raising?? Well I think it could happen end October when the Accounts are written down, and I have every confidence in Vulpes to get the right deal. They must have had a Plan B when they first bought in. And finally good news on trial progression should lead to a higher SP and the doors will be open to all the inflection points that follow. Anything else, a big bonus.

220k and over at 7.035.................

7/7.20..........Nice one

No trade showing yet but MMs 220k at 7.02

Blue sky and no rain, first time for an age, must be snow on the way!!!

MMs are taking 220k+ at 6.913, much like yesterday.

Hoping to see a few more three figure buys today, someone was IMHO certainly loading around 7p yesterday.

And I know you will agree, it is so healthy to have opinions/observations and winning any conversation is not the be and end all, we have all made some good points and I am only happy to take on those points which help me draw my conclusions.

Some choose not to voice an opinion perhaps in fear of doing so, and putting us in a position where the need to criticise is far more than offering an alternative opinion and reasons why they disagree.

There has been a big change here on previous rows last week, respect is something we must uphold, no personals, and hey we did a bit of work on that to ensure ugly scenes are not repeated and we should both be proud of that.

After the run of sells we have seen in recent days, I am 99% sure they are buys. Maybe it is a good sign for the next leg up to see such support as we have seen today, but I take on your comments. As you know I am hardly shy to call sells and I do, even those showing as buys, as happened again this morning, So buys for me, and lets see how we open in the morning as the 570k buy was at 16.31. Goodnight.

Sorry I didn"t respond to you, I fell asleep at 19.30, just woken up and feel as if it should be in the morning. You said..........Knowlesi

Posts: 2,239

Price: 6.95

No Opinion

RE: Up on news - gradual fadeToday 19:37
C7 - recent and not so recent history has a very similar pattern...I can't see any reasons why this time is different.

Well shares go up and shares retrace, and we are seeing 60% rises and 20% odd retraces. On each collaboration we haved move nisely up, the second collaboration aided by the Vulpes Holding RNS produced many blue days from the 5.20 mark to a high of 7.53, I know that because now I have my core holding I was happy to trade my £1500 purchase in the low 5s at 7.52, taking £600 profit and paying what was for me a relatively expensive Xmas. A nd the third collaboration just a short time ago oropelled us from a higher low, early 6s to 8.20/8.50 odd, and again we have retraced 6.70/7.20 a higher low again and found support in 7p plus today with 2 x 250k buys at 7 and a 570k buy at 16.31 for 7.105.

That is I believe emphatic support which we hadn"t seen on two previous occasions, and the collaborations have as a result added considerable value on the M/Cap. It IMHO the Interims/Update can fall any day this week, even next Monday the day before the Conference on February 4th so the SP is a higher low as it stands today, and the only reason why I feel your observation about up on news and gradual fade is true but it has been taking the share higher from the 5.2 Vulpes paid in the market just six week ago.

I find the timing of those three buys very refreshing at this time as we wait for the next update, just a shame we had to fall to 7p to pick them up.

Ray a good list, which can be added too, news of subsequent collaborations will validate the importance of the first three further and give us confidence we have a platform that could finally provide income whilst trials are on their way.

Numerous buysof 100k at 8p, another 1m buy at full ask on Monday, amongst others and since Vulpes Holding RNS at 5.2 we are 40% up in 5.6 weeks. Nicely poised and buyers are hardly deserting us, the daily volumes get higher and remember we hit 60 trades last Monday another new high.

Not so sure that counts as a gradual fade, after the 570k buy it will be an interesting open in the morning, and the MMs taking as many shares as you like at 7.1 and 7.095 should well invrese too. Just IMHO and encouraging pre Interims/ Update due any day.

Buys 1.205m

Sells 511k

-7.33%.........................lol

16:31:36 7.109 570,000 40.52k

Be nice if it is Vulpes!!!

GN

570K at 7.105..............so that is 1.070m bought in 3 buy trades, hence IMHO why we are visiting 7p today

Administrators need to be paid, perhaps part of that 200k is for them.

Buys 635k

Sells 486k

Indeed.......................

Buys 635k

Sells 419k

-7.33%

Still taking 220k+ at 6.915/6.9075

When just 5 weeks ago we received this............................

Director's Dealings
Tue, 17th Dec 2019 12:44

RNS Number : 1881X
Scancell Holdings Plc
17 December 2019

17 December 2019



Scancell Holdings plc

("Scancell" or the "Company")



Director's Dealings



Scancell, the developer of novel immunotherapies for the treatment of cancer, today announces that Vulpes Life Science Fund, a person closely associated with Martin Diggle, Non- Executive Director, has purchased 2,925,000 ordinary shares of 0.1p each ('Ordinary Shares') in the Company on 16 December 2019 at a price of 5.2p per share. Following the purchase Vulpes Life Science Fund holds 80,549,311 ordinary shares representing 17.3% of the company.

Hmmm, 40% UP